Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

5:2

The Fast Diet · Intermittent Energy Restriction

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

8 human trials, about 8 studies, ~3,000 participants across trials. The written rationale for this grade is still being prepared.

FDA
Not a regulated intervention
WADA
Not prohibited

Reference only. Not medical advice.

What can go wrong

Most reported issues are tied to adherence and to the restricted days: high dropout (fasting arms near 29 to 38 percent in Trepanowski/Varady 2017), greater hunger (Sundfor 2018), and fast-day effects such as headache, fatigue, irritability, and difficulty concentrating. The most important safety concern is that any restrictive eating pattern can mask or trigger disordered eating; clinicians and dietitians caution that intermittent fasting can become a socially acceptable cover for restriction. It is generally considered unsuitable for people with a history of an eating disorder, for pregnant or breastfeeding people, for children and adolescents, and for those on glucose-lowering or other food-timed medication without supervision. Long-term data beyond about one year are limited. Anyone considering this pattern, and especially anyone with a history of eating concerns, diabetes, or other medical conditions, should work with a qualified healthcare provider or registered dietitian rather than self-directing. This entry does not provide fasting-day calorie targets or a step-by-step protocol.

The 5:2 protocol is a modified intermittent-fasting pattern in which a person eats normally on five days and substantially reduces intake on two non-consecutive days each week. It is the form of intermittent fasting that Dr. Michael Mosley popularized through a 2012 BBC Horizon program and the 2013 book The Fast Diet. Across randomized trials and a 2024 umbrella review, 5:2-style fasting is associated with weight loss and cardiometabolic changes that are about equal to steady daily calorie restriction, with adherence emerging as the main differentiator. Ēnel is preparing to catalog 5:2 with that equivalence framing front and center, alongside contraindications and a redirect to a qualified provider for anyone with a history of eating concerns. This entry presents the popular method descriptively and attributed, and does not offer fasting-day targets or step-by-step instructions.

Five normal days, two days at 500 to 600 calories. Equivalent to daily dieting, easier to stick to.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Weight loss in adults with overweight or obesity, where 5:2 is associated with results comparable to continuous calorie restriction (Harvie 2011; 2024 umbrella review).
  • Improvements in several cardiometabolic markers such as waist circumference, fasting insulin, triglycerides, and HDL cholesterol, at certainty comparable to or, for HDL, slightly favoring intermittent schedules (2024 eClinicalMedicine umbrella review).
  • Glycemic management in type 2 diabetes under clinical supervision: the EARLY trial (JAMA Network Open 2024, n=405) reported a 5:2 meal-replacement program reduced HbA1c more than metformin or empagliflozin over 16 weeks, a clinician-led use rather than a self-directed one (PMC11193124).
  • An alternative weight-management option some people find more acceptable than daily restriction, which may support engagement for those who prefer a structured two-day pattern (Hajek 2021).

What people get wrong

  • Often saidMyth: 5:2 melts away more weight than ordinary calorie cutting.

    ActuallyFact: head-to-head RCTs (Harvie 2011, Trepanowski/Varady 2017, Sundfor 2018) and the 2024 eClinicalMedicine umbrella review found weight loss about equal to continuous calorie restriction; the popular method is associated with similar, not superior, results (PMC3017674; PMC5680777; PubMed 29778565; PMC10945168).

  • Often saidMyth: People stick to 5:2 more easily because it is only two restricted days.

    ActuallyFact: adherence is the weak point. In Trepanowski/Varady 2017 the fasting arm had the highest dropout (about 38 percent), and in the Hajek 2021 5:2 trial self-reported adherence fell from 74 percent at 6 weeks to 22 percent at one year, though participants rated it more favorably than standard advice (PMC5680777; PMC8598045).

  • Often saidMyth: 5:2 switches on autophagy and other deep cellular renewal that ordinary dieting cannot.

    ActuallyFact: metabolic switching and autophagy are described mainly from animal and short human marker studies; direct human evidence linking 5:2 cycles to clinically meaningful autophagy is limited and contested, and reviewers including de Cabo and Mattson call for more human research (NEJM 2019, NEJMra1905136; NIA summary).

Who profits, and who pushes back

  • Dell Stanford

    Pushes backSenior Dietitian, British Heart Foundation

    Stanford has stated that research suggests the 5:2 diet may help people lose weight at least in the short term, but that it may not be any more effective than other forms of intermittent fasting or traditional low-calorie diets, and that there is a lack of long-term data on its effects (British Heart Foundation).

  • Becky Mehr

    Pushes backRegistered dietitian nutritionist (eating-behavior commentary)

    Mehr has stated that intermittent fasting can sometimes serve as a socially acceptable disguise for disordered eating behaviors, a caution echoed by clinicians who recommend screening before any fasting pattern is adopted (WebMD; clinical commentary, PMC10589984).

  • John Trepanowski and Krista Varady

    Pushes backAuthors, JAMA Internal Medicine alternate-day fasting trial (2017)

    Their randomized trial concluded that alternate-day fasting did not produce superior adherence, weight loss, weight maintenance, or cardioprotection versus daily calorie restriction (PMC5680777).

  • Dr. Michael Mosley†

    Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.

    Promotes itBBC, books

    Sold millions of 5:2 books worldwide. A physician and science communicator; his popularization was generally accurate. Died May 2024.

  • Mainstream dieting community

    Promotes itGlobal

    Widely adopted as a flexible alternative to daily calorie counting.

Where the research comes from

Share of published research by country of origin.
PlaceShare of published research
UK40%
Australia22%
USA22%
Other16%

Research published from: UK, Australia, USA.

How we got here

Periodic abstention from food is ancient and global, not Euro-American in origin. Britannica and historical reviews document fasting in Vedic, Hindu, and Jain traditions in South Asia, in ancient Egyptian priestly purification, in Greek medicine where Hippocrates in the 5th century BCE recommended abstinence for some illnesses, and across Islam (Ramadan, a pillar of the faith), Judaism (Yom Kippur), and Christianity (Lent). Modern structured intermittent fasting draws on 20th and 21st century laboratory work on energy restriction. The specific 5:2 pattern reached the public when Dr. Michael Mosley presented the BBC Horizon program Eat, Fast and Live Longer in 2012; Mosley has said he encountered the approach through researchers including Mark Mattson and Michelle Harvie, whose 2011 randomized trial compared intermittent and continuous restriction. In early 2013 Mosley and journalist Mimi Spencer published The Fast Diet through Short Books, which carried 5:2 into mainstream diet culture.

  1. c. 1500 BCEFasting documented in Vedic, Hindu, and Jain traditions in South Asia (per Britannica and historical reviews).
  2. 5th century BCEHippocrates recommends abstinence from food for certain illnesses in Greek medicine.
  3. 2011Harvie et al. publish a randomized trial in International Journal of Obesity finding intermittent energy restriction as effective as continuous restriction in overweight women (PMC3017674).
  4. 2012Michael Mosley presents the BBC Horizon program Eat, Fast and Live Longer, popularizing the 5:2 approach.
  5. 2013Mosley and Mimi Spencer publish The Fast Diet through Short Books.
  6. 2017Trepanowski and Varady report in JAMA Internal Medicine that alternate-day fasting did not beat daily calorie restriction over one year (PMC5680777).
  7. 2018Sundfor et al. report similar one-year weight loss for intermittent versus continuous restriction, with higher hunger on the intermittent arm (PubMed 29778565).
  8. 2024eClinicalMedicine umbrella review of 23 meta-analyses finds modified-fasting schedules roughly equal to continuous restriction for weight, and less effective for systolic blood pressure (PMC10945168).
  9. 2025Catenacci et al. report in Annals of Internal Medicine that a 4:3 schedule produced modestly greater 12-month weight loss than daily calorie restriction.

At a glance

Pattern
5 normal + 2 low days
Fast-day calories
500-600 kcal
Evidence
Equivalent to daily CR
Best for
Adherence-focused dieters

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about 5:2. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources